Indonesia's Kalbe Farma Reports 14.7 Percent Increase in Net Sales (Indonesia)
This article was originally published in PharmAsia News
Executive Summary
Indonesia's Kalbe Farma reported net sales worth $572 million for the first three quarters of 2007. Ninety-five percent of those sales came from within Indonesia with the other 5 percent accounted for by exports. Overall Kalbe's profits are up 14.69 percent compared to the same time period in 2006. (Click here for more
You may also be interested in...
Darzalex Surpasses Stelara As J&J’s Best-Selling Drug
Sales of Stelara are expected to begin tapering off later this year when the first biosimilars launch in mid-2024 in Europe and later in the US.
Philips Portfolio Includes ‘No Single Product That Does Not Use A Type Of AI,’ Says CEO And AI Thought Leader Roy Jakobs
Philips CEO Roy Jakobs talks to Medtech Insight about the medtech firm’s decade-long history of embedding AI into its products and what he expects from the newly released draft framework by the National Academy of Medicine, which he helped develop as co-chair of the Steering Committee.
MoCRA Stakeholders Reminded Registration Enforcement Begins 1 July: ‘Do Not Delay!’
The Independent Beauty Association urged stakeholders at its Cosmetic Convergence Symposium to take action to ensure they are meeting requirements of the Modernization of Cosmetics Regulation Act come 1 July, when FDA’s enforcement of the facility and product registration deadline begins. Presenters offered tips from companies that have already completed the process.